Zhang T - Search Results

1

Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.

Xiao J, Zhao F, Luo W, Yang G, Wang Y, Qiu J, Liu Y, You L, Zheng L, Zhang T. Xiao J, et al. Among authors: zhang t. Cancer Manag Res. 2024 Jun 21;16:651-661. doi: 10.2147/CMAR.S465098. eCollection 2024. Cancer Manag Res. 2024. PMID: 38919872 Free PMC article.

2

Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.

Zhang GN, Liang Y, Zhou LJ, Chen SP, Chen G, Zhang TP, Kang T, Zhao YP. Zhang GN, et al. Among authors: zhang tp. Cancer Lett. 2011 Dec 27;313(2):137-44. doi: 10.1016/j.canlet.2011.05.030. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 22030254

3

Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China.

Wu Q, Chen G, Wu WM, Zhou L, You L, Zhang TP, Zhao YP. Wu Q, et al. Digestion. 2012;86(4):294-301. doi: 10.1159/000341397. Epub 2012 Oct 23. Digestion. 2012. PMID: 23095334

4

Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer.

Zhou B, Zhang J, Chen G, You L, Zhang TP, Zhao YP. Zhou B, et al. Cancer Lett. 2013 Feb 1;329(1):118-24. doi: 10.1016/j.canlet.2012.10.039. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142291

5

Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer.

Du X, Zhao YP, Zhang TP, Zhou L, Chen G, Cui QC, Shi J, Wang TX, You L, Shu H. Du X, et al. World J Surg. 2013 Jul;37(7):1688-94. doi: 10.1007/s00268-013-2010-0. World J Surg. 2013. PMID: 23568245

6

Human equilibrative nucleoside transporter 1 (hENT1) predicts the Asian patient response to gemcitabine-based chemotherapy in pancreatic cancer.

Xiao JC, Zhang TP, Zhao YP. Xiao JC, et al. Hepatogastroenterology. 2013 Mar-Apr;60(122):258-62. doi: 10.5754/hge12687. Hepatogastroenterology. 2013. PMID: 23574652

7

MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer.

Liu WJ, Zhao YP, Zhang TP, Zhou L, Cui QC, Zhou WX, You L, Chen G, Shu H. Liu WJ, et al. J Gastrointest Surg. 2013 Aug;17(8):1399-405. doi: 10.1007/s11605-013-2230-5. Epub 2013 May 29. J Gastrointest Surg. 2013. PMID: 23715647

8

Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer.

Du X, Zhao YP, Zhang TP, Zhou L, Chen G, Wang TX, You L, Shu H. Du X, et al. Arch Med Res. 2014 Jan;45(1):15-20. doi: 10.1016/j.arcmed.2013.10.001. Epub 2013 Dec 5. Arch Med Res. 2014. PMID: 24316112

9

Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.

Xu JW, Wang TX, You L, Zheng LF, Shu H, Zhang TP, Zhao YP. Xu JW, et al. PLoS One. 2014 Mar 25;9(3):e92847. doi: 10.1371/journal.pone.0092847. eCollection 2014. PLoS One. 2014. PMID: 24667580 Free PMC article. Clinical Trial.

10

N-wasp in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis.

Guo JC, Li J, Zhao YP, Zhou L, Cui QC, Zhou WX, Zhang TP, You L, Shu H. Guo JC, et al. World J Surg. 2014 Aug;38(8):2126-31. doi: 10.1007/s00268-014-2500-8. World J Surg. 2014. PMID: 24718883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,897 results

Search Page

Filters